Interesting! Study of pts w/ ANA(-) & dsDNA(+). 1 in 5 dx with APLS! Have others seen that? I have been disgregarding this pattern, though some of that is related to my in-house assay (seems overly-sensitive) & my bias against overdiagnosis #ACR24 @RheumNow Abstr#2391 https://t.co/FWgCjEwPDK

• https://x.com/EBRheum/status/1858536139990188151/photo/1

Abstract 1876: Developed a machine learning model w/ #SDoH covariates to accurately identify patients with SLE and ESRD in NIH All of US dataset @RheumNow #ACR24 https://t.co/TLDSiBZZPs

• https://x.com/AkhilSoodMD/status/1858536391875113060/photo/1

Provocative study suggests SLE has changed. Big picture: less physical manifestations, more serologic @andreafava why isn't this just more-testing & more-sensitive testing shifting the phenotype of who we diagnose? #ACR24 @RheumNow Abstr#2413 https://t.co/o2e9TFMsUp

• https://x.com/EBRheum/status/1858539160019050703/photo/1
• https://x.com/EBRheum/status/1858539160019050703/photo/1
• https://x.com/EBRheum/status/1858539160019050703/photo/1

Lots of data on TYKs including much supporting efficacy in interferon inhibition Can we really call interferon signalling a "central" pathway in SLE? Inhibiting it has been modestly successful, at best, and mostly for skin dx #ACR24 @RheumNow Abstr#2434 https://t.co/Q94FQz3gzO

• https://x.com/EBRheum/status/1858540166723359064/photo/1

Class V #Lupus Nephritis usually takes longer to treat. Stay the course if no contraindications and taper steroids! - Dr A Askanase #ACR24 LN Guidelines @RheumNow https://t.co/4BBuAWi2da

• https://x.com/KDAO2011/status/1858540969416618215/photo/1
• https://x.com/KDAO2011/status/1858540969416618215/photo/1

Cool study investigating differences in nailfold capillaroscopy, jives w/my clinical experience Compared to SLE, pts with DM 🔼nailfold changes, 🔼 loop dilation, 🔼hemorrhages #ACR24 @rheumnow Abstr#2404 https://t.co/8N7KNRZet8

• https://x.com/EBRheum/status/1858526074323501472/photo/1

Dr. @karen_kc123 discusses the results of the VITAL study. - Long term use of Vit D3 2000IU was safe and decreased the incidence of all autoimmune dses by 22%. - It took a while to work but the effect dissipates once discontinued. @RheumNow #ACR24 @rheumarhyme https://t.co/mnwRsdZ06N

• https://x.com/RHEUMarampa/status/1858528374945124754/photo/1
• https://x.com/RHEUMarampa/status/1858528374945124754/photo/1
• https://x.com/RHEUMarampa/status/1858528374945124754/photo/1
• https://x.com/RHEUMarampa/status/1858528374945124754/photo/1

#ACR24 Guidelines #LupusNephritis for refractory dz @RheumNow https://t.co/LlSixkggKK

• https://x.com/KDAO2011/status/1858532764204593196/photo/1

In earlier studies of Vit D, there were conflicting evidence as to whether it reduced or increased the risk of RA and #SLE @RheumNow #ACR24 @rheumarhyme https://t.co/PvjjmhHaOd

• https://x.com/RHEUMarampa/status/1858516500765712635/photo/1